The global skin antiseptic products market size was valued at USD 218.7 million in 2020 and is anticipated to expand at a CAGR of 6.8% during the forecast period, 2021-2028. The growth of the market is attributed to the rising product demand to meet the increasing occurrences of hospital acquired infections that happen because of lack in precaution and sanitation along with the increasing usage of endoscope reprocesses and surgical units.
Antiseptics are specific chemical agents used in the application of skin and other external parts of the body in order to reduce the bacterial count and thereby reducing the risk of infections which can be contagious.
Every skin antiseptic has their own specific chemical formulae researched by the scientists of their biological firms. Most of these skin antiseptics are unique to one another depending on the region, customer base, and environment (country laws). Some common chemical agents include povidone-iodine, isopropyl alcohol, benzalkonium chloride, hydrogen peroxide, chlorhexidine, chloroxylenol, and hexachlorophene.
Antiseptics have found numerous potential uses such as the prevention of infections on the host’s skin especially for scrapes, minor burns or cuts, dry-handwashing for the healthcare workers between multiple procedures for their patients, treating throat infections by using mouthwashes or lozenges, cleaning the skin of the patient before any medical procedure including injections or operations, and cleaning the mucous membranes for treating infections.
According to the World Health Organization or the WHO, along with the Centers for Disease Control and Prevention or the CDC, one in every 25 hospital patients will be having healthcare associated infection across the globe. The COVID-19 pandemic has boosted the growth of the global skin antiseptic products market initially. Every health organization in the world declared that the usage of sanitizers will significantly decrease the widespread of this disease. This steered to hospitals, clinics, and healthcare laboratories to focus more on skin antiseptic products be it in hand-wash form, soap, or sanitizers.
The report on the global skin antiseptic products market size includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Skin Antiseptic Products Market Size - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Formulations (Alcohols, Chlorhexidine, Iodine, Octenidine, and Others), Types (Solutions, Swab Sticks, and Wipes), and Applications (Surgeries [Spinal, Joints, and Others] |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast |
Key Players Covered in the Report |
3M; EcoLab; BD; Sage Products LLC; B.Braun Melsungen AG; Johnson & Johnson; and Schulke & Mayer GmbH |
Based on formulations, the global skin antiseptic products market is divided into alcohols, chlorhexidine, iodine, octenidine, and others. The alcohol segment is expected to constitute the major share of the market in 2019. The major reason attributing to this market growth is the rising use of alcohol formulations for pre-operative and pre-injection skin operations. There is also an increased demand for alcohol as it easily available, the chemical formulae are simple, and can be used for other formulation combinations including chlorhexidine and iodine.
Meanwhile the octenidine segment is anticipated to grow with a significant CAGR during the forecast period, 2021-2028, owing to the availability of new applications. Octenidine is currently used as a substitute for iodine and chlorhexidine as it has more efficacy and has lower side-effects comparatively.
On the basis of types, the global skin antiseptic products market is divided into solutions, swab sticks, and wipes. The solutions segment is expected to constitute the major share of the market in 2019 owing to the increasing occurrences of SSIs & hospital acquired infections and the ease of availability for solutions. There is also an increase in awareness and growing new applications for antiseptic solutions, be it in pre-injection or pre-operation skin preparation.
Meanwhile the wipes segment is anticipated to grow with a significant CAGR during the forecast period due to the ease of use along with the tape and film adhesion. They are also more effective in wound applications than other segments.
Based on the applications, the global skin antiseptic products market is bifurcated into surgeries and injections. The surgeries and injections are further divided into spinal, joints, and others. The injection segment is expected to constitute the major share of the market in 2019 and is anticipated to grow with a significant CAGR during the forecast period, 2021-2028. The major reason attributing to this market growth is the rising usage of injections for the extraction of fluids from the swollen joints of the patient for the injection of medicines. Injections are also less complicated with lower cost and are still as effective as a surgery.
On the basis of regions, the global skin antiseptic products market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is expected to constitute a major share in 2020. This regional market growth can be attributed to the growing research & development expenditure along with the rising in adoption of the latest technology.
The demand of skin antiseptic products is increasing rapidly in this region due to the presence of the major market players in the skin antiseptic products market, an advantage other regions do not have. The cost of expenditure is significantly lower in North America than that of other economies. However, the market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period, 2021-2028, as they have prioritized the cost-efficiency perspective of skin antiseptic products combined with their growing population.
The global skin antiseptic products market size has been segmented in terms of
Major players competing in the global skin antiseptic products market are 3M; EcoLab; BD; Sage Products LLC; B.Braun Melsungen AG; Johnson & Johnson; and Schulke & Mayer GmbH. These market players are involved in several business strategies such as mergers, acquisitions partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. Schulke & Mayer GmbH initiated a distribution agreement in February 2019 with DKSH, which is one of the leading market service providers in China. As per this agreement, DKSH will be distributing Schulke & Mayer GmbH products throughout China.
Some other reports from this category!